Target Name: MIR4275
NCBI ID: G100422937
Review Report on MIR4275 Target / Biomarker Content of Review Report on MIR4275 Target / Biomarker
MIR4275
Other Name(s): microRNA 4275 | hsa-miR-4275 | hsa-mir-4275 | MicroRNA 4275

Introduction to MIR4275, A Potential Drug Target

MIR4275, also known as microRNA-4275, is an important molecule that has gained significant attention in the field of medical research. This small non-coding RNA molecule is involved in various cellular processes and has been identified as a potential drug target and biomarker for several diseases. In this article, we will explore the role of MIR4275 in health and disease and discuss its potential applications in medicine.

The Discovery of MIR4275

MIR4275 was first discovered through advanced molecular biology techniques that have revolutionized the field of genomics. MicroRNAs are a class of small RNA molecules involved in the regulation of gene expression. Researchers initially identified several microRNAs in various organisms, including humans, but their specific functions remained largely unknown.

In recent years, advancements in DNA sequencing technologies have enabled scientists to identify and characterize numerous microRNAs. One such microRNA is MIR4275, which was discovered through high-throughput sequencing methodologies. Its presence and functional relevance were confirmed in multiple experimental models, leading to increased interest in understanding its role in cellular processes.

MIR4275 as a Drug Target

Recent studies have shed light on the potential of MIR4275 as a drug target for various diseases. MicroRNAs, including MIR4275, play a crucial role in regulating gene expression by binding to the messenger RNA (mRNA) molecules and inhibiting their translation into proteins. Dysregulation of microRNAs can disrupt normal cellular processes, contributing to the development and progression of diseases.

Several studies have shown that aberrant expression of MIR4275 is associated with various pathological conditions. For instance, it has been implicated in certain types of cancer, including breast, lung, and liver cancer. Targeting MIR4275 using novel therapeutic strategies, such as antisense oligonucleotides or small molecule inhibitors, has shown promising results in preclinical studies. These approaches aim to restore the balance of MIR4275 expression and thereby inhibit the growth and progression of cancer cells.

In addition to cancer, MIR4275 has also been implicated in other diseases, such as cardiovascular disorders, neurological disorders, and immune-related conditions. The precise mechanisms through which MIR4275 contributes to these diseases are not yet fully understood. However, ongoing research is aimed at elucidating its regulatory roles in specific cellular pathways, which may help identify potential drug targets for therapeutic interventions.

MIR4275 as a Biomarker

Biomarkers play a crucial role in diagnosing diseases, monitoring treatment response, and predicting patient outcomes. MIR4275 has demonstrated potential as a biomarker for various diseases due to its high stability and detectability in various biofluids, including blood, urine, and saliva.

In cancer research, MIR4275 has shown promise as a non-invasive biomarker for early detection and monitoring of tumor progression. Its presence and expression levels in biofluids reflect the molecular changes that occur during tumor development and metastasis. Therefore, monitoring MIR4275 levels can provide valuable diagnostic and prognostic information for clinicians.

Moreover, MIR4275 has shown potential as a biomarker for drug response prediction. By assessing MIR4275 expression levels before and during treatment, clinicians can potentially tailor therapies to individual patients, maximizing treatment efficacy and minimizing adverse effects.

Conclusion

MIR4275 is an intriguing molecule that holds great promise as both a drug target and biomarker. Its dysregulation has been implicated in various diseases, making it an attractive target for therapeutic interventions. Furthermore, its stable presence and detectability in various biofluids make it an excellent candidate for biomarker development.

As research continues to unravel the functional significance of MIR4275 in cellular processes and disease pathology, it is expected that novel therapeutic strategies and diagnostic tools will be developed. These advancements will undoubtedly improve patient outcomes and pave the way for personalized medicine in the future.

Protein Name: MicroRNA 4275

The "MIR4275 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4275 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456